At a glance
The September 14, 2020, Clinical Laboratory COVID-19 Response (CLCR) call included updates on the interim final rule from CMS, technical guidance for implementation of laboratory data reporting, and laboratory data reporting for COVID-19, as well as an FDA update.
Agenda
Welcome: Jasmine Chaitram, CDC Division of Laboratory Systems (DLS)
CMS Update on Interim Final Rule – Laboratory Reporting: Regina Van Brakle and Amy Zale, Centers for Medicare & Medicaid Services (CMS)
Technical Guidance for Implementation of Laboratory Data Reporting: Mike Waters, Testing and Diagnostics Task Force, U.S. Department of Health and Human Services (HHS)
Laboratory Data Reporting for COVID-19 – A Clinical Laboratory Experience: Jordan Olson, Geisinger Health System, Department of Laboratory Medicine
FDA Update: Tim Stenzel, U.S. Food and Drug Administration (FDA)